Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck presents three series of IGF-1R and IRR inhibitors

Nov. 21, 2003

Novel antiangiogenic agents revealed in recent Abbott patent

Nov. 20, 2003

Roche claims new c-Met kinase inhibitors and their use in cancer therapy

Nov. 20, 2003

Pivotal trial commences for Acapodene in advanced prostate cancer

Nov. 20, 2003

Italian phase III trial for ADI in liver cancer

Nov. 19, 2003

TopoTarget initiates phase I U.K. study of PXD-101

Nov. 17, 2003

Sanofi-Synthelabo presents new bFGF antagonists for cancer and other disorders

Nov. 17, 2003

New progesterone receptor modulators under investigation at Akzo Nobel

Nov. 17, 2003

YM BioSciences and Oncoscience sign licensing agreement for TheraCIM hR3

Nov. 14, 2003

Grant supports development of Resmycin

Nov. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...